AdrenoCo
Natural health product licensed in Canada
- Licence holder
- Integria Healthcare (Australia) Pty Ltd
- NPN or DIN-HM
- 80123031
- Status
- Active licence
- Licence date
- 3 February 2023
- Revision date
- 7 March 2023
- Form
- Comprimé
- Route of administration
- Orale
- Application type
- Générale (non traditionelle)
If this product were sold in France
- Conditions légales
Glycyrrhiza glabra L.: La portion journalière recommandée ne doit pas conduire à une ingestion d'acide glycyrrhizinique supérieure à 100 mg. L'étiquetage doit comporter un avertissement avec la teneur suivante: "Ne pas utiliser pendant plus de 6 semaines sans avis médical." L'étiquetage doit comporter un avertissement déconseillant l'emploi chez les enfants.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Glycyrrhiza glabra Source : Glycyrrhiza glabra - racine Extract : Matériel brut sec Extraction ratio : 12:1 Dry plant equivalent : 2,307.6 mg Potency : 25 mg Glycyrrhizin | 192.3 mg | Not calculated |
| Rehmannia glutinosa Extract : Matériel brut sec Extraction ratio : 5:1 Dry plant equivalent : 750 mg | 150 mg | Not calculated |
Non-medicinal ingredients
Phosphate de calcium dibasique dihydraté, Cellulose microcristalline, Dioxyde de silicium, Hypromellose, Croscarmellose de sodium, Stéarate de magnésium, Glycolate d'amidon sodique
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 18 years | 1 Comprimé | 3 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Glycyrrhiza glabra is traditionally used in Herbal Medicine as an expectorant to help relieve chest complaints, such as mucous buildup catarrhs, coughs and bronchitis. Used in Herbal Medicine to help relieve inflammatory conditions of the gastrointestinal tract, such as gastritis in adults. Used in Herbal Medicine as an adrenal tonic.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Source
Official Health Canada record, licence 80123031
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2023. Photograph the packaging to check whether it has changed.
Has the product changed? Photograph the packaging.